The medicine
"Klabaks" describes the instructions for use as an antibiotic of semi-synthetic origin, which is the last generation macrolide. The basis of this drug is the suppression of protein synthesis directly in the pathogenic cell due to interaction with the ribosomal subunit of the microbe. Use antibiotic "Klabaks" application instructions advises to exert a pronounced antibacterial, bacteriostatic and bactericidal effects on the body. The main analogues of this medicine, which have a similar effect, are today such drugs as Criksan, Binoklar, Klaritrosin, Klaritsit, Arvitsin and Fromilid.
The antibiotic "Klabaks" is available in the form of granules intended for the preparation of a suspension, and in the form of tablets. All of these forms contain clarithromycin as an active ingredient. The granules also include substances such as croscarmellose sodium, microcrystalline cellulose, hydroxypropyl cellulose, hypromellose and alginic acid. The tablets contain povidone, water, MCC,
magnesium stearate, talc, silicon dioxide,
stearic acid and croscarmellose sodium.
To use the drug βKlabaksβ, the instructions for use recommends, mainly, to eliminate various bacterial infections provoked by microorganisms sensitive to clarithromycin. For example, for the treatment of SARS, chronic bronchitis, tonsillitis, sinusitis, laryngitis, pharyngitis and other inflammatory diseases of the lower or upper respiratory tract. With impetigo, folliculitis, furunculosis, wound infections and otitis media, you should also start taking the Klabaks antibiotic. Indications for use include diseases such as chlamydia, mycobacteriosis (including atypical mycobacteriosis), duodenal ulcer and gastric ulcer.

It is strictly not recommended to prescribe this antibacterial agent if the patient has an increased sensitivity to clarithromycin, erythromycin or any other macrolides. In addition, the Klabaks preparation is not recommended for use in case of porphyria, hypokalemia, hepatitis, and also in combination with astemizole, cisapride, pimozide or terfenadine. With great caution, it is necessary to take this medicine in case of liver or kidney failure. In addition, it is not recommended to prescribe this antibiotic to persons under six months of age due to a lack of necessary clinical trial experience.
As for the possible side effects, the use of this drug can cause the development of candidal stomatitis, leukopenia, hypoglycemia and cholestasis. Diarrhea, nausea, inflammation of the tongue, dyspepsia, paresthesia, urticaria, headache, insomnia, dizziness, hallucinations, disorientation, tinnitus, depersonalization and psychosis may occur.